Table 1 Participant characteristics
Characteristic | Value |
|---|---|
Total patients: N | 51 |
Female: n, (%) | 35 (68.6) |
Age (years): median, (IQR) | 34, (28 - 45) |
WHO stage: n, (%) | |
1 | 21 (40.7) |
2 | 22 (43.3) |
3 | 5 (10.0) |
4 | 3 (6.0) |
Reason for testing: n, (%) | |
ART eligibility | 13 (25.0) |
ART monitoring | 38 (75.0) |
CD4+ T cells: median, (IQR) | 507.5, (271.75 - 744.5) |